Center for Health, Identity, Behavior & Prevention Studies, New York University, New York, NY, USA.
Prev Sci. 2010 Jun;11(2):219-27. doi: 10.1007/s11121-009-0164-7.
Prevention researchers have advocated primary prevention such as vaccination in alternative venues. However, there have been major questions about both the attendance of, and the ability to, vaccinate high-risk individuals in such settings. The current study seeks to assess the feasibility of vaccinating high-risk men who have sex with men (MSM) at Gay Pride events. The research questions are: Do gay men who are sampled at Gay Pride events engage in more or less risky behavior than gay men sampled at other venues? Do the gay men who receive hepatitis vaccinations at Gay Pride engage in more or less risky behavior than gay men at Gay Pride who do not receive hepatitis vaccination? Of the 3689 MSM that completed the Field Risk Assessment (FRA), 1095/3689 = 29.68% were recruited at either the 2006 or 2007 Long Beach, California Gay Pride events. The remaining, 2594/3689 = 70.32% were recruited at Long Beach gay bars, gay community organizations and institutions, and through street recruitment in various gay enclaves in the Long Beach area. Logistic regression analysis yielded eight factors that were associated with non-attendance of Gay Pride: Age, had sex while high in the last 12 months, had unprotected anal intercourse (UAI) in the last 12 months, had sex for drugs/money in the last 12 months, been diagnosed with a sexually transmitted infection (STI) in the last 12 months, used nitrites (poppers) in the last 12 months, and used methamphetamine in the last 12 months. Identifying as White, Asian, or African American compared to Hispanic was also associated with non-attendance. Bivariate analysis indicated that, of the MSM sampled at Gay Pride, 280/1095 = 25.57% received a hepatitis vaccination there. The MSM sampled at Gay Pride who reported engaging in UAI or having used any stimulant (cocaine, crack-cocaine, or methamphetamine) in the last 12 months were more likely to receive hepatitis vaccination on-site. The results provide evidence for the viability of successfully vaccinating high-risk MSM at Gay Pride events. However, it is vital that no-cost vaccinations are also funded in other community settings such as STI clinics, drug treatment programs, prisons, universities, and other community resource centers in order to reach those additional high-risk MSM who do not attend Gay Pride.
预防研究人员提倡在替代场所进行初级预防，如接种疫苗。然而，人们对在这些环境中为高风险人群接种疫苗的出勤率和能力存在重大疑问。本研究旨在评估在同性恋骄傲活动中为男男性接触者（MSM）接种疫苗的可行性。研究问题是：在同性恋骄傲活动中抽样的男同性恋者比在其他场所抽样的男同性恋者进行的性行为风险更大还是更小？在同性恋骄傲活动中接受肝炎疫苗接种的男同性恋者比未接受肝炎疫苗接种的男同性恋者进行的性行为风险更大还是更小？在完成现场风险评估（FRA）的 3689 名男同性恋者中，有 1095/3689=29.68%是在 2006 年或 2007 年加利福尼亚州长滩的同性恋骄傲活动中招募的。其余的，2594/3689=70.32%是在长滩的同性恋酒吧、同性恋社区组织和机构以及通过在长滩地区的各种同性恋飞地进行街头招募招募的。逻辑回归分析得出了八个与不参加同性恋骄傲活动有关的因素：年龄、过去 12 个月内高风险性行为、过去 12 个月内无保护肛交、过去 12 个月内为性交易/金钱进行性行为、过去 12 个月内被诊断患有性传播感染（STI）、过去 12 个月内使用亚硝酸酯（嗅盐）、过去 12 个月内使用冰毒。与西班牙裔相比，自认为是白人、亚洲人或非裔美国人也与不参加有关。双变量分析表明，在参加同性恋骄傲活动的男同性恋者中，有 280/1095=25.57%在那里接种了肝炎疫苗。在同性恋骄傲活动中抽样的报告在过去 12 个月内进行无保护肛交或使用任何兴奋剂（可卡因、快克可卡因或冰毒）的男同性恋者更有可能在现场接种肝炎疫苗。结果为在同性恋骄傲活动中成功为高危 MSM 接种疫苗提供了证据。然而，至关重要的是，在其他社区环境中，如性传播感染诊所、戒毒治疗计划、监狱、大学和其他社区资源中心，也需要为无成本疫苗接种提供资金，以便为那些不参加同性恋骄傲活动的其他高危 MSM 提供疫苗接种。
